Effect of Intravenous Administration of Liposomal Prostaglandin E1 on Microcirculation in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention
Background: Several studies have demonstrated that primary percutaneous coronary intervention (PCI) can result in reperfusion injury. This study aims to investigate the effectiveness of liposomal prostaglandin E1 (Lipo-PGE1, Alprostadil, Beijing Tide Pharmaceutical Co., Ltd.) for enhancing microcirc...
Main Authors: | Li-Ye Wei, Xiang-Hua Fu, Wei Li, Xi-Le Bi, Shi-Ru Bai, Kun Xing, Yan-Bo Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2015-01-01
|
Series: | Chinese Medical Journal |
Subjects: | |
Online Access: | http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=9;spage=1147;epage=1150;aulast=Wei |
Similar Items
-
Association of thrombocytopenia and infection in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention
by: Litao Wang, et al.
Published: (2021-08-01) -
Electrocardiogram predictors of multivessel disease in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
by: Ajay Kumar Sharma, et al.
Published: (2021-01-01) -
OUTCOMES OF TRANSRADIAL APPROACH IN PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: Amna Rashdi, et al.
Published: (2020-12-01) -
Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
by: Gao L, et al.
Published: (2014-07-01) -
Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
by: Yan Li, et al.
Published: (2020-01-01)